ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #8,512Hybrid

Nanomedicine

Abbreviation (ISO):NANOMEDICINE-UK
•
Identifier (ISSN):1743-5889(Print)/1748-6963(Online)
•
Publisher:Future Medicine Ltd.
Clarivate IF (2026)
4.6↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Nanomedicine

WoS Q2
2468520184.7220194.320205.3120216.120225.520234.720243.920254.62026
Annual Impact Factor Metric
Current (2026):4.6
Scopus SJR & RankScopus Q1
0.681
#8,512

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
148

148 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate4.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
149articles/year
5.94% Gold OA•65.17% Original Research

Aims & Scope

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond. As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches. Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.

Topics Covered (Recognized by AI)
BiologyMaterials ScienceMedicineChemistryNanotechnologyPhysicsEngineeringGeneticsChemical EngineeringBiochemistryQuantum MechanicsOrganic ChemistryInternal MedicinePharmacologyPsychologyPsychiatry

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q2
Rank54/180
IndexSCIE
JCRSCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Q2
Rank71/148
IndexSCIE
JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank107/180
IndexSCIE
JCISCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Q3
Rank80/148
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.6
Articles / Year136
Total Citations78
2025
IF3.9
Articles / Year240
Total Citations1,014
2024
IF4.7
Articles / Year225
Total Citations1,811
2023
IF5.5
Articles / Year187
Total Citations1,573
2022
IF6.096
Articles / Year141
Total Citations2,142

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,512Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Chemical EngineeringEngineeringMaterials ScienceMedicineSocial Sciences
Scopus Citation Rank (SJR)Q1
0.681

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.96

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,104 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,884
3-Year Documents468
Citable Documents403

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DevelopmentQ1
BioengineeringQ2
Biomedical EngineeringQ2
Materials Science (miscellaneous)Q2
Medicine (miscellaneous)Q2
Nanoscience and NanotechnologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区BIOTECHNOLOGY & APPLIED MICROBIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Nanomedicine (abbr: NANOMEDICINE-UK, ISSN: 1743-5889) is a peer-reviewed international scholarly journal in the field of Medicine, published by Future Medicine Ltd. in England since 2006. The periodical holds a Journal Impact Factor (JIF) of 4.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.681 (Q1), an H-index of 148.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 149 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,104 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Future Medicine Ltd.
Publication Language
English
Frequency
Monthly
Founding Year
2006
Indexing & Databases
SCIEScopusPubMed
Editorial Address
FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 3efdef67-205d-44cd-9e0a-c134db8e0b50
Database Updated: 2026-09-28